What will happen once COVID is

2022-03-10

What will happen once COVID is over? Will thecompany have other products to keep it growing?

Why Moderna Stock Was a Big Winner on Wednesday

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

wanyan
2022-03-10
wanyan
mRNA technology can further be explore into curing Cancer or AIDs etc.. so it's still a technology to invest
NEWBIE
2022-03-10
NEWBIE
I wonder yoo

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":9038495381,"tweetId":"9038495381","gmtCreate":1646880134562,"gmtModify":1676534173198,"author":{"id":4105682868479180,"idStr":"4105682868479180","authorId":4105682868479180,"authorIdStr":"4105682868479180","name":"mac0racle","avatar":"https://static.itradeup.com/news/4dc37b66a531fcae6a5c31754d48f122","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":3,"crmLevelSwitch":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.11.15","exceedPercentage":"60.25%","individualDisplayEnabled":0},"individualDisplayBadges":[],"fanSize":4,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>What will happen once COVID is over? Will thecompany have other products to keep it growing?</p></body></html>","htmlText":"<html><head></head><body><p>What will happen once COVID is over? Will thecompany have other products to keep it growing?</p></body></html>","text":"What will happen once COVID is over? Will thecompany have other products to keep it growing?","highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/9038495381","repostId":1103212716,"repostType":4,"repost":{"id":"1103212716","kind":"news","pubTimestamp":1646879268,"share":"https://www.laohu8.com/m/news/1103212716?lang=&edition=full","pubTime":"2022-03-10 10:27","market":"us","language":"en","title":"Why Moderna Stock Was a Big Winner on Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1103212716","media":"Motley Fool","summary":"A high-profile investor delightedly piled into the stock.What happenedNever underestimate the power ","content":"<html><head></head><body><p>A high-profile investor delightedly piled into the stock.</p><p><b>What happened</b></p><p>Never underestimate the power of famous pundits to move a stock&#39;s price. That power was strongly in evidence on Wednesday, when a notable figure in financial media revealed he had snapped up shares of <b>Moderna</b>. In the wake of that announcement, the biotech company&#39;s stock price shot more than 10% higher for the session.</p><p><b>So what</b></p><p>This happy investor is Josh Brown, a high-profile financial writer, blogger, and CNBC commentator, who revealed that he&#39;d bought Moderna stock at what he termed a &#34;ludicrous&#34; price of $125 per share. In doing so, he obtained the stock at a lower level than all of its daily closing prices thus far in 2022.</p><p>In an interview that aired on CNBC, Brown asserted that Moderna has far more value than its recent share prices would indicate.</p><p>&#34;This was a $500 stock that fell to $125,&#34; he said, &#34;and to be frank, I think it&#39;s one of the most cutting edge, technologically exciting companies of all the publicly traded opportunities in the pharma/biotech/healthcare space.&#34;</p><p>Moderna, a top coronavirus stock that performed well in the more intense phases of the pandemic, has lost some of its luster since then. That&#39;s due in part to the declines in the numbers of both daily new COVID-19 cases and daily fatalities in recent weeks. Those numbers have fallen rapidly in many parts of the world as the omicron wave of the crisis recedes.</p><p><b>Now what</b></p><p>Moderna leaped to fame and fortune as a COVID-19 vaccine developer, and its widely distributed Spikevax remains one of only three COVID-19 vaccines either approved or authorized for emergency use by the Food and Drug Administration.</p><p>But the company is harnessing its mRNA-based technology to develop products to treat and prevent a range of afflictions, and as such, it has excellent potential to be far more than just a flash-in-the-pan coronavirus stock.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Moderna Stock Was a Big Winner on Wednesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Moderna Stock Was a Big Winner on Wednesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-10 10:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/03/09/why-moderna-stock-was-a-big-winner-on-wednesday/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>A high-profile investor delightedly piled into the stock.What happenedNever underestimate the power of famous pundits to move a stock's price. That power was strongly in evidence on Wednesday, when a ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/03/09/why-moderna-stock-was-a-big-winner-on-wednesday/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://www.fool.com/investing/2022/03/09/why-moderna-stock-was-a-big-winner-on-wednesday/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1103212716","content_text":"A high-profile investor delightedly piled into the stock.What happenedNever underestimate the power of famous pundits to move a stock's price. That power was strongly in evidence on Wednesday, when a notable figure in financial media revealed he had snapped up shares of Moderna. In the wake of that announcement, the biotech company's stock price shot more than 10% higher for the session.So whatThis happy investor is Josh Brown, a high-profile financial writer, blogger, and CNBC commentator, who revealed that he'd bought Moderna stock at what he termed a \"ludicrous\" price of $125 per share. In doing so, he obtained the stock at a lower level than all of its daily closing prices thus far in 2022.In an interview that aired on CNBC, Brown asserted that Moderna has far more value than its recent share prices would indicate.\"This was a $500 stock that fell to $125,\" he said, \"and to be frank, I think it's one of the most cutting edge, technologically exciting companies of all the publicly traded opportunities in the pharma/biotech/healthcare space.\"Moderna, a top coronavirus stock that performed well in the more intense phases of the pandemic, has lost some of its luster since then. That's due in part to the declines in the numbers of both daily new COVID-19 cases and daily fatalities in recent weeks. Those numbers have fallen rapidly in many parts of the world as the omicron wave of the crisis recedes.Now whatModerna leaped to fame and fortune as a COVID-19 vaccine developer, and its widely distributed Spikevax remains one of only three COVID-19 vaccines either approved or authorized for emergency use by the Food and Drug Administration.But the company is harnessing its mRNA-based technology to develop products to treat and prevent a range of afflictions, and as such, it has excellent potential to be far more than just a flash-in-the-pan coronavirus stock.","news_type":1},"isVote":1,"tweetType":1,"viewCount":147,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":77,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":100778309,"commentId":"100778309","gmtCreate":1646881631612,"gmtModify":1663244903627,"authorId":3563196147337980,"author":{"id":3563196147337980,"idStr":"3563196147337980","authorId":3563196147337980,"name":"wanyan","avatar":"https://static.tigerbbs.com/5cd6127ccb204f5f868bc820cb45e234","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9038495381,"objectIdStr":"9038495381","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"mRNA technology can further be explore into curing Cancer or AIDs etc.. so it's still a technology to invest","text":"mRNA technology can further be explore into curing Cancer or AIDs etc.. so it's still a technology to invest","html":"mRNA technology can further be explore into curing Cancer or AIDs etc.. so it's still a technology to invest","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0},{"id":100778257,"commentId":"100778257","gmtCreate":1646881327707,"gmtModify":1663244902958,"authorId":3573124416025977,"author":{"id":3573124416025977,"idStr":"3573124416025977","authorId":3573124416025977,"name":"NEWBIE","avatar":"https://static.tigerbbs.com/3efe20248e6d34805e6c7befc3ae66a0","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9038495381,"objectIdStr":"9038495381","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"I wonder <u>yoo</u>","text":"I wonder <u>yoo</u>","html":"I wonder <u>yoo</u>","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/9038495381"}